EPCAM and hepatocellular carcinoma: The anti-EpCAM single-chain variable fragment (scFv) is fused to the anti-CD3 scFv via a Gly4Ser linker to form the bispecific T-cell engager (BITE), whose binding to γδ T cells can lead to near-complete lysis of HCC cell lines in vitro (45).